Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
General article on CBD: insert-text-here
They’re buying cbd stocks as well. It’s not a coincidence that republicans are the ones to push it forward.
True, all the govt. officials and ex-officials love to shoot their mouths off. Makes you wonder why so many are always so anxious to give their opinions.
There isn’t any statistical evidence.. so he’s right. It’s mostly anecdotal. But someone please tell that to the consumer, lol, and we’ll wait 2 years before some real analysis comes out.
This guy did not help out the CBD industry today:
https://www.msn.com/en-ca/video/money/there-is-no-evidence-of-cbd-benefits-says-former-fda-commissioner/vi-BBVQRL8
So many people I run across in business and personal know nothing about CBD. I think we are golden with these companies. When people catch on look out!
Nice pull back entry point on this today.
Outside market influences seemed to be under control...I was worried about Brexit but that is undercontrol...Also qe have more states signing hemps laws weekly
I hope you’re right!
This stock want 20$ im buying more in the am
ELLXF looks like a prime candidate for M&A.
Good read. Brief mention of Elixinol and Charlotte's Web.
https://www.forbes.com/sites/alanjbrochstein/2019/04/07/mergers-and-acquisitions-light-up-the-cannabis-sector/#5b040f4887e4
I loaded more at 3.85 this stock will continue up.
I like the cooling off. No doubts that this will take and hold the $4's
Lol I briefly invested in “other rival” a few months back hoping that it would get pumped and I could make a short-term profit. I sold the day before it hit $7 because it was all too shady for me. I’d say that “other rival” is one of the most likely stocks of the cannabis boom to be engaging in some fraudulent activities...
If we beat the other rival that is 5.75 i will lmfao...All those guys will be pissed lol...ellxf
ELLXF vs VFRM(cbd products comparisons)
1)ELLXF and VFRM are CBD/Hemp stocks
2)ELLXF= $4.22 per shrare
3)VFRM= $0.89 per share(less than $1. per share)
4)ELLXF products are NOT in CVS stores.
5)VFRM CBD products are in CVS stores.
6)VFRM operates a 140-acre farm and production facilities in Pueblo, Colorado, U.S.A.
This thing just opens up and trades sideways everyday. pretty remarkable.. still holding my early entries, but may let go some of my higher purchases. We’ll see. So far though so good, and super hot sector too. So why not
Great start to the week in Australia. Look slike we could break and hold the $4s this week.
Australian listing, EXL, up ~10%. How far can we go?
Can't go wrong with either one and it's amazing how many articles mention both of them..the class of the pack, IMO.
I can’t wait for the day that this pps is where Cweb is now.
CW and Ellxf are the 2 I like.
Excellent article thanks for sharing! I liked the end where they said if you want to try it buy the #1 CW!
Excellent article: Fake CBD – How to Tell if CBD Oil is Real or Fake
https://www.nanalyze.com/2019/03/fake-cbd-oil-real-fake/
Could’ve would’ve should’ve life is full of them GLTU
I wish I could go back in time and tell myself to buy MORE at 2.50! Go baby go!
And without any news. Sweet.
New 52wk high.. First hit @4 !!!
Dazed and confused: States push for legal clarity on CBD
https://www.kcra.com/article/dazed-confused-states-push-for-legal-clarity-on-cbd-cannabis/27047306
AP Updated: 1:53 PM PDT Apr 4, 2019
By PAUL ELIAS/Associated Press
SOURCE: KCRA
SAN FRANCISCO (AP) —
CBD oil-infused gummy bears, lattes and other food, drinks and dietary supplements are selling quickly even though the U.S. government says they're illegal and local authorities have forced some retailers to pull products. The confusion has the nation's two largest states and others moving to legalize the cannabis compound that many see as beneficial to their health.
Lawmakers in Texas and California are often in opposition, but they're both pushing bipartisan legislation to sidestep federal law and allow sales of the compound found in hemp and marijuana. Republicans and Democrats in Congress also are urging the U.S. Food and Drug Administration to change its stance.
Advertisement
The FDA announced Tuesday that it will hold a public hearing in May to gather more information.
Resolving the confusion can't come quick enough for Jonathan Eppers, who makes Vybes, a popular CBD oil-infused beverage. California health inspectors raided his Los Angeles warehouse in January and impounded $100,000 worth of the drink.
Eppers said about 50 California retailers have since dropped his product and he's moved production to Texas. He estimates lost sales, legal costs and relocation expenses have cost him at least $500,000.
"What is going on is unbelievable and asinine," Eppers said. "They put us in this state of limbo that's costing us."
Eppers and CBD fans are mystified by the legal insecurity. After all, they say, retailers in California and nine other states that have broadly legalized marijuana sell edibles and other products that get people high, though pot is illegal under federal law. U.S. officials generally have taken a hands-off approach in states where pot is legal.
The FDA has oversight of CBD because it is the active ingredient in an approved prescription drug to treat two rare seizure disorders. The agency says CBD can't be added to food or sold as a dietary supplement because officials haven't determined if it's safe or effective for other conditions.
FDA Commissioner Scott Gottlieb told Congress last week that enforcement is being limited to sellers who make false health claims. He says the agency recently sent warning letters to three companies touting CBD as a treatment for cancer, Alzheimer's disease, fibromyalgia and drug addiction.
"But there are products on the market right now that, given our enforcement priorities and our limited resources, we haven't taken action against," he said.
Sellers and users say CBD helps with pain, anxiety and inflammation, though limited scientific research supports those claims. It's turning up in products ranging from lotions, cosmetics and soap to diet pills, juices, cocktails, candy and drinks.
Short for cannabidiol, CBD is a non-psychoactive molecule found in hemp and marijuana. Both are cannabis plants, but only marijuana has enough of the compound THC to get users high. CBD oil is extracted when the plant is processed. While hemp derivatives are essentially THC-free, CBD oil from marijuana may have very little or enough to produce a high.
State and local officials are taking nearly all the enforcement actions against CBD. Health officials in California, which has the nation's largest marijuana marketplace, warned retailers last summer that anything edible containing CBD is illegal until lawmakers or regulators say otherwise.
The warning was largely ignored until early 2019, when state and local health officials began forcing some small businesses to pull products after receiving complaints.
San Francisco health officials recently barred two small operators from selling CBD-infused food and drink, while authorities in rural Grass Valley, 140 miles away, did the same to a small, cooperatively owned grocery store.
"It caught us way off guard," said Gus Dabais, owner of Sidewalk Wellness, one of the stores targeted.
The San Francisco Health Department sent warning letters to 1,900 businesses last year, spokeswoman Veronica Vien said. She said inspectors are not looking for CBD but responding to complaints.
She said that's how they ended up "red tagging" products at Dabais' business and Steap Tea Bar, a popular Chinatown stop that sold CBD-infused bubble tea.
Similar scenarios are playing out in Ohio, where authorities in January ordered a Cincinnati grocery store to remove CBD from two outlets. The following month, New York City health inspectors removed CBD products from a number of restaurants. Police in March raided two Fort Worth, Texas, retailers and seized CBD products after the local district attorney declared the compound illegal.
In Texas, one of a handful of states that outlaws all forms of marijuana, lawmakers are pushing a measure that would legalize hemp oil-infused edibles. It sailed through its first committee in the House this week.
In California, a similar CBD measure has moved on to the full Assembly.
"A number of people have been using it for years, and you can find it on retail shelves all over the place, but now people are surprised to find it's against the law," said Assemblywoman Cecilia Aguiar-Curry, a Napa-area Democrat who introduced the measure. "What this bill will do is clear up the confusion."
She said the legislation would stop state and local enforcement of the FDA's ban and hopes it becomes law by August.
"This would lift a legal cloud from a legitimate California business," said Jim Gross of the U.S. Hemp Roundtable, an industry association.
A growing number of federal lawmakers, including Senate Majority Leader Mitch McConnell and Democratic Sen. Ron Wyden of Oregon, are urging the FDA to approve CBD. They backed a measure taking hemp off the U.S. government's list of banned substances.
"Hemp is a versatile crop with many uses and applications," McConnell and Wyden wrote to the FDA in February. "We are hopeful that by working with you on the implementation of our legislation, we can help ensure that hemp can be a new cash crop for farmers across the country."
Follow this story to get instant e-mail alerts from KCRA on the latest developments and related topics.
Might be a dumb question, but is converting the ASX offering's price from AUD to USD a fair way to estimate the way the OTC offering will move the next day? EXL currently up .35, or 7.14%, to 5.25--which converts to 3.74 USD.
Found it
It is up in APRIL
DESCRIPTION
Elixinol Global Ltd. engages in the industrial hemp and medical cannabis business in Australia.
It manufactures and distributes industrial hemp-based dietary supplements, foods, and skincare products in the USA.DESCRIPTION
Elixinol Global Ltd. engages in the industrial hemp and medical cannabis business in Australia.
It manufactures and distributes industrial hemp-based dietary supplements, foods, and skincare products in the USA.
Streetwise Reports Examines Best-of-Breed Hemp/CBD Producers
GlobeNewswire•April 3, 2019
https://finance.yahoo.com/news/streetwise-reports-examines-best-breed-110000634.htmlSAN FRANCISCO, April 03, 2019 (GLOBE NEWSWIRE) -- Fincom Investment Partners surveys the hemp-CBD landscape and discusses two companies it believes are "best of breed."
Company mentioned: Elixinol Global Ltd. (EXL:ASX; ELLXF:OTCQX)
The hemp/CBD phenomena grows. Investors appear to be catching on. Our universe of publicly traded CBD "pure-plays" suggests the two "best-of-breed."
Charlotte's Web Holdings Inc. and Elixinol Global Ltd. are pioneers in hemp/CBD. Both are fast growers. Elixinol, the fastest over the second half of 2018, has new, cutting-edge products and a lower relative valuation. This balances with Charlotte's Web's stronger name recognition and larger retail sales base. Charlotte's Web's Q4 sales rebounded after a hiccup in Q3 and had solid Q/Q sales growth of 21%. Both companies have positive EBITDA, which must be a shock to cannabis investors, with what we believe is a superior business model to cannabis growers. (Disclosure: A director of Fincom Investment Partners is a long-time Charlotte's Web reseller).
We continue to suggest fair valuation for Elixinol remains one-half of Charlotte's Web's—discounted 20%. Charlotte's Web's sales are more than 2X.
Elixinol's 2018 sales were US$26 million, up 121% annually. Charlotte's Web's were $69 million, up 74% annually. Much of Elixinol sales are in lower margin private label, which becomes a strategic advantage since neither Charlotte's Web nor CV Sciences can boast significant experience with private label, third party or bulk CBD sales. Elixinol, perhaps, has a "leg up" on branded partnerships, building the "powered by Elixinol" brand—the brand behind the brands. We believe this is a stronger competitive "moat" than just selling through fickle retailers.
We have long argued CBD (the cannabidiols, a non-intoxicant) is a larger market—and a better investment—than cannabis.
Continue reading this article: Best-of-Breed Hemp/CBD Producers
hi there, great read; $ELLXF
just got on; Elixinol Global Limited (ASX: EXL; - n.y.s.e.'Elixinol Global Ltd. (ELLXF)'
NEW YORK, Sept. 18, 2018 /PRNewswire/ -- OTC Markets Group Inc.
(OTCQX: OTCM), operator of financial markets for 10,000 U.S. and
global securities, today announced Elixinol Global Limited (ASX: EXL;
Couldn't agree more, ANIA77. ELLXF $5.15 on ASX.
This is a must read for whoever wondering if CBD is better place to invest than MJ stocks..
I invest solely based on numbers. I always analyze financial reports and particularly look for good margins and profitability.. and CBD companies are unbeatable when it comes to that and this article proves it.
Great info. Thanks for sharing
This is why we are all in CBD... we have another gap up again today.. this what you get when stock is so thin.
Got it - thanks!
CAMPAIGN TO EDUCATE MEDIA ABOUT FDA’S PLAN FOR CBD
HERE IS WHAT THE MEDIA ISN’T REPORTING ON THE FDA AND CBD
This is a timestamped clip of an interview with FDA Commissioner Dr. Scott Gottlieb at the Brookings Institute on 3/19/19
You only need to watch it for 2 minutes to get the complete gist of what the FDA is going to do with CBD in 2019
It begins at 30:25 and you can stop listening at 32:30
Followers
|
26
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1174
|
Created
|
09/18/18
|
Type
|
Free
|
Moderators |
50 Pitt Street,
Level 6
Sydney, NSW 2000
Australia
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |